Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 4, 2011, Pages 459-466

  Ko, Dennis T ^a,b,c   Wijeysundera, Harindra C ^b,c   Yun, Lingsong ^a   Austin, Peter C ^a   Cantor, Warren J ^c,d   Tu, Jack V ^a,b,c  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

Author keywords

Acute coronary syndrome; Death; Percutaneous coronary intervention; Statin therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DRUG EFFICACY; DRUG USE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RECURRENT DISEASE;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ANGIOPLASTY; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PREOPERATIVE CARE; TREATMENT OUTCOME;

EID: 80054739232     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.111.960740     Document Type: Article

References (21)

1. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497
2. Winchester DE, Wen X, Xie L, Bavry AA. Evidence of pre-procedural statin therapy: A meta-analysis of randomized trials. J Am Coll Cardiol. 2010;56:1099-1109
3. Zhang F, Dong L, Ge J. Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A meta-analysis. Ann Med. 2010;42:171-177
4. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study. Circulation. 2004;110:674-678 (Pubitemid 39056265)
5. Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: Results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol. 2007;49:1272-1278 (Pubitemid 46467240)
6. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol. 2009;54:558-565
7. Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, Mussardo M, Montorfano M, Ricciardelli B, Colombo A. Novel approaches for preventing or limiting events (Naples) II trial: Impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol. 2009;54:2157-2163
8. Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome. Int J Cardiol. 2009;137:246-251
9. Eagle KA, Chopra V. Statins before coronary procedures. a new indication for an old friend. J Am Coll Cardiol. 2010;56:1110-1112
10. Ellis SG, Anwaruddin S. Recapturing the magic: Revisiting the pleiotropic effects of statins in percutaneous coronary revascularization. J Am Coll Cardiol. 2009;54:566-568
11. Nallamothu BK, Bates ER. Periprocedural myocardial infarction and mortality: Causality versus association. J Am Coll Cardiol. 2003;42: 1412-1414 (Pubitemid 37267282)
12. Kushner FG, Hand M, Smith SC Jr., King SB III, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr.. 2009 Focused updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2205-2241
13. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart Disease and Stroke Statistics: 2010 update: A report from the American Heart Association. Circulation. 2009;121:e46-e215
14. Ko DT, Chiu M, Guo H, Austin PC, Goeree R, Cohen E, Labinaz M, Tu JV. Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications. J Am Coll Cardiol. 2009;53: 1773-1782
15. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, Hopkins R, Tarride JE, Blackhouse G, Lazzam C, Cohen EA, Goeree R. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med. 2007;357: 1393-1402 (Pubitemid 47541971)
16. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA. 2008;300:1765-1773
17. Ko DT, Newman AM, Alter DA, Austin PC, Chiu M, Cox JL, Goodman SG, Tu JV. Secular trends in acute coronary syndrome hospitalization from 1994 to 2005. Can J Cardiol. 2010;26:129-134
18. Austin PC, Mamdani MM. A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use. Stat Med. 2006;25:2084-2106 (Pubitemid 43950281)
19. Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV. The use of the propensity score for estimating treatment effects: Administrative versus clinical data. Stat Med. 2005;24:1563-1578 (Pubitemid 40716354)
20. Chan AW. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation. 2001;105:691-696
21. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504. (Pubitemid 38477774)